Akebia Therapeutics Statistics

Total Valuation

AKBA has a market cap or net worth of $305.81 million. The enterprise value is $340.69 million.

Market Cap	305.81M
Enterprise Value	340.69M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

AKBA has 268.26 million shares outstanding. The number of shares has increased by 21.26% in one year.

Current Share Class	268.26M
Shares Outstanding	268.26M
Shares Change (YoY)	+21.26%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	40.96%
Float	262.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.32
Forward PS	1.61
PB Ratio	11.16
P/TBV Ratio	n/a
P/FCF Ratio	5.09
P/OCF Ratio	5.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.09, with an EV/FCF ratio of 5.67.

EV / Earnings	n/a
EV / Sales	1.47
EV / EBITDA	28.09
EV / EBIT	31.41
EV / FCF	5.67

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 7.22.

Current Ratio	1.40
Quick Ratio	1.30
Debt / Equity	7.22
Debt / EBITDA	11.53
Debt / FCF	3.29
Interest Coverage	0.51

Financial Efficiency

Return on equity (ROE) is -78.96% and return on invested capital (ROIC) is 3.05%.

Return on Equity (ROE)	-78.96%
Return on Assets (ROA)	2.02%
Return on Invested Capital (ROIC)	3.05%
Return on Capital Employed (ROCE)	5.75%
Weighted Average Cost of Capital (WACC)	6.74%
Revenue Per Employee	$1.20M
Profits Per Employee	-$105,727
Employee Count	194
Asset Turnover	0.69
Inventory Turnover	2.56

Taxes

In the past 12 months, AKBA has paid $1.75 million in taxes.

Income Tax	1.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.02% in the last 52 weeks. The beta is 0.25, so AKBA's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-69.02%
50-Day Moving Average	1.15
200-Day Moving Average	1.66
Relative Strength Index (RSI)	59.39
Average Volume (20 Days)	6,087,268

Short Selling Information

The latest short interest is 27.42 million, so 10.22% of the outstanding shares have been sold short.

Short Interest	27.42M
Short Previous Month	26.37M
Short % of Shares Out	10.22%
Short % of Float	10.46%
Short Ratio (days to cover)	5.24

Income Statement

In the last 12 months, AKBA had revenue of $232.40 million and -$20.51 million in losses. Loss per share was -$0.08.

Revenue	232.40M
Gross Profit	190.43M
Operating Income	10.85M
Pretax Income	-18.76M
Net Income	-20.51M
EBITDA	12.13M
EBIT	10.85M
Loss Per Share	-$0.08

Full Income Statement

Balance Sheet

The company has $162.64 million in cash and $197.52 million in debt, giving a net cash position of -$34.88 million or -$0.13 per share.

Cash & Cash Equivalents	162.64M
Total Debt	197.52M
Net Cash	-34.88M
Net Cash Per Share	-$0.13
Equity (Book Value)	27.38M
Book Value Per Share	0.10
Working Capital	69.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $60.37 million and capital expenditures -$335,000, giving a free cash flow of $60.04 million.

Operating Cash Flow	60.37M
Capital Expenditures	-335,000
Depreciation & Amortization	1.28M
Net Borrowing	-4.35M
Free Cash Flow	60.04M
FCF Per Share	$0.22

Full Cash Flow Statement

Margins

Gross margin is 81.94%, with operating and profit margins of 4.67% and -8.83%.

Gross Margin	81.94%
Operating Margin	4.67%
Pretax Margin	-8.07%
Profit Margin	-8.83%
EBITDA Margin	5.22%
EBIT Margin	4.67%
FCF Margin	25.83%

Dividends & Yields

AKBA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.26%
Shareholder Yield	-21.26%
Earnings Yield	-6.71%
FCF Yield	19.63%

Analyst Forecast

The average price target for AKBA is $4.20, which is 268.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.20
Price Target Difference	268.42%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	-5.01%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AKBA has an Altman Z-Score of -4.43 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.43
Piotroski F-Score	5